Literature DB >> 10394881

Overexpression of human telomerase RNA is an early event in oesophageal carcinogenesis.

T Hiyama1, H Yokozaki, Y Kitadai, K Haruma, W Yasui, G Kajiyama, E Tahara.   

Abstract

Telomerase, the ribonucleoprotein enzyme that elongates telomeres, is repressed in normal human somatic cells but is reactivated during tumour progression. The purpose of this study was to investigate the localization of human telomerase RNA (hTR) expression in human oesophageal dysplasia and cancer by using in situ mRNA hybridization (ISH) with avidin-biotin staining. Ki-67 immunoreactivity was also examined. We analysed 51 squamous cell carcinomas, 9 dysplasias and 60 normal mucosae. The integrity of the mRNA in each sample was verified by using a poly d(T)20 probe. Seventy-six samples (63%) showed no mRNA degradation; these included 30 carcinomas, 7 dysplasias and 39 normal mucosae. At the single-cell level, high levels of hTR expression were found in the cytoplasm and especially in the nucleus. Most (>90%) cancer cells demonstrated high levels of hTR expression in 29 (97%) of the 30 tumours. Most dysplastic cells also showed high levels of hTR in all 7 dysplastic cases. In all 39 normal mucosae, most basal cells indicated high levels of hTR expression, which were also seen in infiltrating lymphocytes. The distribution of hTR-expressing cells was similar to that of Ki-67-positive cells. These data suggest that overexpression of hTR may be correlated with the proliferative activity that defined by Ki-67 immunoreactivity and is an early event in carcinogenesis of the oesophagus.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10394881     DOI: 10.1007/s004280050372

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  12 in total

1.  Telomerase reverse transcriptase expression is increased early in the Barrett's metaplasia, dysplasia, adenocarcinoma sequence.

Authors:  R V Lord; D Salonga; K D Danenberg; J H Peters; T R DeMeester; J M Park; J Johansson; K A Skinner; P Chandrasoma; S R DeMeester; C G Bremner; P I Tsai; P V Danenberg
Journal:  J Gastrointest Surg       Date:  2000 Mar-Apr       Impact factor: 3.452

2.  Epidermal growth factor receptor and mutant p53 expand an esophageal cellular subpopulation capable of epithelial-to-mesenchymal transition through ZEB transcription factors.

Authors:  Shinya Ohashi; Mitsuteru Natsuizaka; Gabrielle S Wong; Carmen Z Michaylira; Katharine D Grugan; Douglas B Stairs; Jiri Kalabis; Maria E Vega; Ross A Kalman; Momo Nakagawa; Andres J Klein-Szanto; Meenhard Herlyn; J Alan Diehl; Anil K Rustgi; Hiroshi Nakagawa
Journal:  Cancer Res       Date:  2010-04-27       Impact factor: 12.701

3.  Effects of cadmium on telomerase activity, expressions of TERT, c-myc and P53, and apoptosis of rat hepatocytes.

Authors:  Wentao Dai; Huajie Chen; Rian Yu; Lingfei He; Bing Chen; Xuemin Chen
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2010-12-22

4.  Copy number changes of target genes in chromosome 3q25.3-qter of esophageal squamous cell carcinoma: TP63 is amplified in early carcinogenesis but down-regulated as disease progressed.

Authors:  Chueh-Chuan Yen; Yann-Jang Chen; Chin-Chen Pan; Kai-Hsi Lu; Paul Chih-Hsueh Chen; Jiun-Yi Hsia; Jung-Ta Chen; Yu-Chung Wu; Wen-Hu Hsu; Liang-Shun Wang; Min-Hsiung Huang; Biing-Shiung Huang; Cheng-Po Hu; Po-Min Chen; Chi-Hung Lin
Journal:  World J Gastroenterol       Date:  2005-03-07       Impact factor: 5.742

5.  Progressive transformation of immortalized esophageal epithelial cells.

Authors:  Zhong-Ying Shen; Li-Yan Xu; Min-Hua Chen; Jian Shen; Wei-Jia Cai; Yi Zeng
Journal:  World J Gastroenterol       Date:  2002-12       Impact factor: 5.742

6.  Telomere and telomerase in the initial stage of immortalization of esophageal epithelial cell.

Authors:  Zhong-Ying Shen; Li-Yan Xu; En-Min Li; Wei-Jia Cai; Min-Hua Chen; Jian Shen; Yi Zeng
Journal:  World J Gastroenterol       Date:  2002-04       Impact factor: 5.742

7.  Insulin-like growth factor-binding protein-3 promotes transforming growth factor-{beta}1-mediated epithelial-to-mesenchymal transition and motility in transformed human esophageal cells.

Authors:  Mitsuteru Natsuizaka; Shinya Ohashi; Gabrielle S Wong; Azal Ahmadi; Ross A Kalman; Daniela Budo; Andres J Klein-Szanto; Meenhard Herlyn; J Alan Diehl; Hiroshi Nakagawa
Journal:  Carcinogenesis       Date:  2010-05-31       Impact factor: 4.944

Review 8.  Perspectives of long non-coding RNAs in cancer.

Authors:  Arunagiri Kuha Deva Magendhra Rao; Thangarajan Rajkumar; Samson Mani
Journal:  Mol Biol Rep       Date:  2017-04-08       Impact factor: 2.316

Review 9.  Chemoprevention of esophageal squamous cell carcinoma.

Authors:  Gary D Stoner; Li-Shu Wang; Tong Chen
Journal:  Toxicol Appl Pharmacol       Date:  2007-03-15       Impact factor: 4.219

Review 10.  Inhibition of human esophageal squamous cell carcinomas by targeted silencing of tumor enhancer genes: an overview.

Authors:  Jalil Pirayesh Islamian; Mohsen Mohammadi; Behzad Baradaran
Journal:  Cancer Biol Med       Date:  2014-06       Impact factor: 4.248

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.